Dr. Reddy’s Laboratories Ltd. ADR (NYSE: RDY) is -11.27% lower on its value in year-to-date trading and has touched a low of $13.61 and a high of $16.89 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RDY stock was last observed hovering at around $14.15 in the last trading session, with the day’s loss setting it -0.14%.
Currently trading at $14.01, the stock is -8.34% and -5.30% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.78 million and changing -0.99% at the moment leaves the stock -7.62% off its SMA200. RDY registered 2.70% gain for a year compared to 6-month loss of -12.51%. The firm has a 50-day simple moving average (SMA 50) of $14.7942 and a 200-day simple moving average (SMA200) of $15.16614.
The stock witnessed a -8.85% gain in the last 1 month and extending the period to 3 months gives it a -12.04%, and is -5.53% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.64% over the week and 1.63% over the month.
Dr. Reddy’s Laboratories Ltd. ADR (RDY) has around 27048 employees, a market worth around $11.67B and $3.72B in sales. Current P/E ratio is 18.22 and Fwd P/E is 17.35. Profit margin for the company is 17.25%. Distance from 52-week low is 2.91% and -17.06% from its 52-week high. The company has generated returns on investments over the last 12 months (16.88%).
with sales reaching $83.23B over the same period.The EPS is expected to shrink by -0.83% this year, but quarterly earnings will post 15.91% year-over-year. Quarterly sales are estimated to grow 17.50% in year-over-year returns.
Dr. Reddy’s Laboratories Ltd. ADR (RDY) Top Institutional Holders
The shares outstanding are 833.12M, and float is at 833.06M with Short Float at 1.57%.
The top institutional shareholder in the company is JPMORGAN CHASE & CO with over 0.64 million shares valued at $48.67 million. The investor’s holdings represent 1.9149% of the RDY Shares outstanding. As of 2024-06-30, the second largest holder is ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. with 2.07 million shares valued at $157.65 million to account for 1.2427 of the shares outstanding. The other top investors are ROYAL BANK OF CANADA which holds 2.06 million shares representing 1.2345% and valued at over $156.61 million, while MORGAN STANLEY holds 1.2191 of the shares totaling 2.03 million with a market value of $154.67 million.
Dr. Reddy’s Laboratories Ltd. ADR (RDY) Insider Activity
#####
